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ing transcription factors. It is possible 
that a similar strategy of targeting MOF 
to promoters with specific transcription 
factors or transcription machinery is 
present in the fly.
Several important questions with gen-
eral implications are brought to light by 
the Kind et al. study. What are the appar-
ently independent mechanisms of MOF 
targeting to the 5′ and 3′ ends of genes? 
Given that MOF acetylates H4K16 at both 
sites, what is the molecular function of 
H4K16 acetylation at these two regions? 
MOF is undoubtedly representative of 
many enzymes and chromatin-asso-
ciated proteins that perform different 
functions through regulated targeting. 
The answers to the questions raised by 
the new work should help to elucidate 
general mechanisms for how specificity 
in targeting allows the same protein to 
perform distinct and independent regu-
latory functions.
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Capping proteins limit actin filament growth, but paradoxically increase actin-based cell motility. 
This has been attributed to funneling of actin monomers to the filament ends that remain uncapped. 
Using a reconstituted motility system, Akin and Mullins (2008) now demonstrate that filament 
capping increases Arp2/3-based nucleation and branching, rather than elevating the rate of fila-
ment elongation.Although actin can polymerize into fila-
ments on its own, cells use an army of 
proteins to control the starting and stop-
ping of this reaction, as well as to orga-
nize the filaments into useful structures. 
Studying the function and regulation of 
these actin-modulating proteins has 
been the work of many labs for several 
decades. The control of actin dynam-
ics is not a mere academic curiosity, 
but plays a key role in physiological 
processes such as morphogenesis and 
immune system function as well as in 
diseases such as metastatic cancer.
Two important factors for controlling 
actin dynamics are the Arp2/3 complex, 
which nucleates new filaments and con-comitantly anchors them to the sides of 
existing filaments, and the capping pro-
tein, which binds to the rapidly growing 
barbed ends of filaments and terminates 
their growth (reviewed in Pollard and 
Borisy, 2003). Although these factors 
have been extensively studied in vitro, 
the relationship between their biochemi-
cal activities and their effects on motil-
ity is complex. This is particularly true 
of capping proteins that block filament 
growth yet enhance cell motility in vitro 
and in vivo (van der Gucht et al., 2005; 
Hug et al., 1995). One explanation for this 
paradoxical set of observations is the 
“actin funneling hypothesis,” which pos-
its that capping proteins enhance motil-Cell ity by capping most actin filaments in 
the reaction and funneling the increased 
number of free actin monomers onto a 
small subset of filaments that grow with 
higher rates of elongation (Carlier and 
Pantaloni, 1997) (Figure 1A).
In their new study, Akin and Mullins 
(2008) re-examine this question and 
come to a strikingly different conclu-
sion about the role of capping protein 
in enhancing motility. They used an 
established in vitro motility system (Loi-
sel et al., 1999) comprising polystyrene 
beads coated with the Arp2/3-activator 
ActA. These beads were incubated in a 
precise mixture of purified protein com-
ponents including nonmuscle actin, the 133, May 30, 2008 ©2008 Elsevier Inc. 765
Arp2/3 complex, capping protein, cofilin, 
and profilin. This system allowed them to 
visualize the initiation of actin assembly 
that occurs in a shell around the beads 
and the subsequent symmetry breaking 
event that leads to sustained movement 
of the beads on rocket tails of branched, 
polymerizing actin filaments.
Using this approach, they system-
atically varied the concentration of the 
Arp2/3 complex and capping protein to 
test several tenets of the actin funnel-
ing hypothesis. Consistent with previous 
work, they found that an increase in cap-
ping protein increased the rate of bead 
motility. One clear prediction of the actin 
funneling hypothesis is that increas-
ing capping protein should increase the 
concentration of actin monomers; this 
in turn should lead to faster rates of fila-
ment elongation on the few uncapped 
filaments in the reaction. On the con-
figure 1. capping Protein (cP) Activity and Actin Architecture
(A) The actin funneling hypothesis proposes that capping protein enhances cell motility by capping most 
actin filaments in the reaction and funneling the increased number of free actin monomers onto a small 
subset of filaments that grow with higher rates of elongation. The enhanced elongation rate on the un-
capped filaments is represented by chevrons on the barbed ends. 
(B) Electron micrographs of lamellipodia showing varying CP activity. 
(C) Based on their analysis of actin filament nucleation and elongation in a motility system reconstituted in 
vitro, Akin and Mullins (2008) propose the monomer gating hypothesis. They observe that the ratio of the 
Arp2/3 complex to actin increases with higher levels of CP, indicating an increase in nucleation. This effect 
arises due to higher local availability of actin monomers when more filaments are capped. Given that actin 
monomers are essential for Arp2/3-based nucleation, more monomers means more nucleation rather than 
increased barbed-end elongation. (Electron micrographs from Bear et al., 2002.)766 Cell 133, May 30, 2008 ©2008 Elsevier Inc.trary, increasing capping protein had 
no effect on actin monomer concentra-
tion in these reactions despite the clear 
increase in bead movement. Two other 
predictions of the actin funneling hypoth-
esis are that the rate of filament growth 
on the bead surface should increase and 
that the number of filaments contributing 
to motility will decrease with increased 
concentration of capping protein. Again, 
the rate of filament elongation and the 
number of filaments were unaffected by 
increased capping protein.
So why does increasing the cap-
ping protein concentration lead to 
increased motility? The authors pos-
tulate an intriguing alternate hypoth-
esis: Increased capping protein leads 
to enhanced nucleation mediated by 
Arp2/3. In their experiments, increasing 
the capping protein concentration led 
to an increased number of capped fila-
ments, as expected. However, the total 
number of filaments remained constant, 
suggesting that increased nucleation 
must be occurring. Indeed, the ratio of 
the Arp2/3 complex to actin increases 
with higher levels of capping protein, 
indicating that more nucleation is hap-
pening. This effect arises due to higher 
local availability of actin monomers at 
the bead surface when more filaments 
are capped. Given that actin mono-
mers are essential for Arp2/3-based 
nucleation, more monomers means 
more nucleation rather than increased 
barbed-end elongation. The authors 
term this the “monomer gating model” 
(Figure 1C).
This notion of momomer gating has 
important implications for interpreting 
some previous studies and will influence 
future work in this area. Factors such 
as the Ena/VASP proteins that inhibit 
capping of actin filaments though an 
anticapping effect would be predicted 
to indirectly decrease Arp2/3 branch-
ing. Indeed, this is entirely consistent 
with studies where Ena/VASP proteins 
are targeted to the plasma membrane 
or added to in vitro reconstitution sys-
tems and branch frequency is reduced 
(Figure 1B) (Bear et al., 2002; Samarin et 
al., 2003). It will be interesting to see if 
other anticapping proteins such as form-
ins also decrease branching in reconsti-
tution systems that include Arp2/3 and 
capping protein.
Although this study breaks important 
new ground, it will be useful to further 
verify this effect in the more complex envi-
ronment found inside cells. A key experi-
ment will be to analyze the effect of inositol 
phospholipids, such as PIP2, on this pro-
cess given that they regulate both Arp2/3-
activating proteins (such as N-WASP) and 
capping protein. It will also be exciting to 
see these ideas incorporated into future 
biophysical models of actin polymeriza-
tion-induced force generation.The signals delivered by members of 
the transforming growth factor β (TGF-β) 
protein family are central to the specifi-
cation of germ cell identity in embryonic 
development. In the endoderm, mater-
nal factors activate the expression of 
TGF-β ligands that in turn induce over-
lying cells to become mesoderm (Figure 
1). Yet, how this induction remains con-
fined to cells lying at the equator of the 
embryo leaving the ectoderm pluripotent 
remains unclear (Niehrs, 2004). Recent 
embryological and molecular evidence 
argues that the development of a pluri-
potent ectoderm appears to result from 
an active molecular process in which 
cells constantly keep TGF-β signaling 
in check. For example, prior to gastrula-
tion, the embryo requires an ectoderm-
specific maternal determinant, Ecto-
dermin/Tif1γ, that ubiquitinates Smad4, 
inhibiting its activity (Dupont et al., 
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germ layers have been induced, TGF-β 
then takes on other duties. At the gas-
trula stage, TGF-β ligands signal through 
Smad2 to start dividing the ectoderm 
into neural and non-neural territories 
along the dorsoventral axis (Figure 1) 
(Chang and Harland, 2007). Paradoxi-
cally, this event is not temporally isolated 
from mesoderm induction (Camus et al., 
2006). It is unclear how embryos seam-
lessly orchestrate what appear to be 
diametrically opposing needs: avoiding 
TGF-β-mediated transformation of the 
ectoderm into mesoderm while at the 
same time using TGF-β for ectodermal 
patterning.
The work of Sasai et al. (2008) in this 
issue of Cell provides an elegant solution 
to this conundrum (Sasai et al., 2008). 
They clone, from the frog Xenopus, a 
new ectoderm-specific gene encod-
ing XFDL156, which has the remarkable 
capacity to uncouple TGF-β responses 
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from mesodermal differentiation. The 
real surprise and excitement about this 
discovery comes from its mechanism of 
action—XFDL156 is a new antagonist of 
the p53 tumor suppressor that leaves the 
TGF-β/Smad pathway operational.
Expression cloning in Xenopus 
embryos was the route taken to this 
discovery (Smith and Harland, 1992). It 
is remarkable that in the era of short-
interfering RNA (siRNA) libraries and 
genome-wide mutagenesis screens, 
this straightforward and purely gain-of-
function approach continues to uncover 
some of the most interesting new 
genes, suggesting that we are still far 
from saturation. As in any screen, the 
experimental strategy is critical. Sasai 
et al. searched almost 20,000 genes 
specifically expressed at the end of 
gastrulation and assayed for those able 
to inhibit TGF-β induction of mesoderm 
in explanted ectoderm cells.
e tgf-β 
Padua, viale Colombo 3, 35126 Padua, Italy
 responses. Sasai et al. (2008) 
ryonic development, this factor 
potency of ectodermal cells by 
n.
